| Literature DB >> 29676445 |
Katrine S Fridthjof1, Peter Kampmann1, Anne Dünweber1, Jette S Gørløv1, Connie Nexø1, Lone S Friis1, Kristina H Nørskov1, Pernille C Welinder1, Claus Moser2, Lars Kjeldsen1, Tom Møller3.
Abstract
Based on experience with comprehensive patient involvement, we present data from implementation of portable, programmable infusion pumps (PPP) for home-based chemotherapy administration in patients with acute leukaemia and in lymphoma patients receiving (carmustine, etoposide, cytarabine, melphalan) BEAM regimen. Data from 84 patients, receiving 177 cycles of PPP administered chemotherapy, showed convincing safety with minor equipment errors encountered and with high patient satisfaction. In-hospital days could be reduced with 52% out of a total of 1197 treatment days. Homebased PPP has several advantages from a patient perspective and furthermore frees up in-hospital beds for patients in need of them.Entities:
Keywords: HSC transplantation; acute leukaemia; chemotherapy; patient involvement; programmable infusion pump
Mesh:
Substances:
Year: 2018 PMID: 29676445 DOI: 10.1111/bjh.15249
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998